Quality of life in Dutch patients with primary biliary cholangitis: Discrepancies between patients' perspectives and objective disease parameters

被引:3
作者
de Veer, Rozanne C. [1 ]
van Hooff, Maria C. [1 ]
da Silva, Geraldine [1 ]
Harms, Maren H. [1 ]
Metselaar, Herold J. [1 ]
Willemse, Jose [2 ]
Utomo, Elaine
van der Meer, Adriaan J. [1 ,3 ]
机构
[1] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Dutch Liver Patients Assoc, Hoogland, Netherlands
[3] Erasmus MC, Dept Gastroenterol & Hepatol, Doctor Molewaterpl 40,NA Bldg,Floor 6, NL-3015 GD Rotterdam, Netherlands
关键词
health-related quality of life; primary biliary cholangitis; CIRRHOSIS; VALIDATION; FATIGUE; IMPACT; ACID;
D O I
10.1111/hepr.13880
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimThis study aims to assess the health-related quality of life (HRQoL) in a Dutch population of patients with primary biliary cholangitis (PBC) in relation to the prognosis and need for second line-therapy, based on both objective disease parameters and patients' perspectives. MethodsIn this cross-sectional multicenter study, HRQoL was assessed by using the Dutch PBC-40 according to objective clinical parameters and patients' perspectives on treatment and prognosis. ResultsIn total, 178/269 (66%) patients responded; mean age 61.2 (SD 9.9) years and 165 (92.7%) women. The PBC-40 domain scores did not differ according to the GLOBE score response (p > 0.05 for all) or according to the POISE criteria (p > 0.05), except for the domain itch (p = 0.031). Patients who considered their survival to be impaired scored higher on all domains as compared to those expecting a normal prognosis (p < 0.05). Similarly, PBC-40 domain scores were higher among patients who considered that they were in need of additional therapy compared to those who did not (p < 0.05 for all, except for domain itch [p = 0.056]). However, 45/62 (72.6%) patients with a self-expected impaired prognosis had a GLOBE score indicative of a normal prognosis. Twenty-five of the 40 (62.5%) patients who believed they needed additional therapy were below POISE criteria. ConclusionThe HRQoL of patients with PBC was impaired in terms of nonfavorable disease status according to the expectations of patients, but not according to objective disease parameters. Substantial discrepancies between patients' perspectives and objective parameters were observed, which highlights the need for better patient guidance among patient with PBC.
引用
收藏
页码:401 / 408
页数:8
相关论文
共 21 条
  • [1] Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid
    Carbone, Marco
    Mells, George F.
    Pells, Greta
    Dawwas, Muhammad F.
    Newton, Julia L.
    Heneghan, Michael A.
    Neuberger, James M.
    Day, Darren B.
    Ducker, Samantha J.
    Sandford, Richard N.
    Alexander, Graeme J.
    Jones, David E. J.
    [J]. GASTROENTEROLOGY, 2013, 144 (03) : 560 - +
  • [2] Measurement properties of the PBC-40 and PBC-27: a Dutch validation study
    de Veer, Rozanne C.
    da Silva, Geraldine
    van Hooff, Maria C.
    Harms, Maren H.
    Metselaar, Herold J.
    Willemse, Jose
    Utomo, Elaine
    van der Meer, Adriaan J.
    [J]. BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01):
  • [3] The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis
    Dyson, J. K.
    Wilkinson, N.
    Jopson, L.
    Mells, G.
    Bathgate, A.
    Heneghan, M. A.
    Neuberger, J.
    Hirschfield, G. M.
    Ducker, S. J.
    Sandford, R.
    Alexander, G.
    Stocken, D.
    Jones, D. E. J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (10) : 1039 - 1050
  • [4] Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis
    Efe, Cumali
    Tascilar, Koray
    Henriksson, Ida
    Lytvyak, Ellina
    Alalkim, Fatema
    Trivedi, Hirsh
    Eren, Fatih
    Eliasson, Johanna
    Beretta-Piccoli, Benedetta Terziroli
    Fischer, Janett
    Caliskan, Ali Riza
    Chayanupatkul, Maneerat
    Coppo, Claudia
    Ytting, Henriette
    Purnak, Tugrul
    Muratori, Luigi
    Werner, Marten
    Muratori, Paolo
    Rorsman, Fredrik
    Onnerhag, Kristina
    Gunsar, Fulya
    Nilsson, Emma
    Heurgue-Berlot, Alexandra
    Guzelbulut, Fatih
    Demir, Nurhan
    Gonen, Can
    Semela, David
    Aladag, Murat
    Kiyici, Murat
    Schiano, Thomas
    Montano-Loza, Aldo
    Berg, Thomas
    Ozaslan, Ersan
    Yoshida, Eric
    Bonder, Alan
    Marschall, Hanns-Ulrich
    Wahlin, Staffan
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (07) : 1101 - 1108
  • [5] EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
    Hirschfield, Gideon M.
    Beuers, Ulrich
    Corpechot, Christophe
    Invernizzi, Pietro
    Jones, David
    Marzioni, Marco
    [J]. JOURNAL OF HEPATOLOGY, 2017, 67 (01) : 145 - 172
  • [6] Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis
    Jacoby, A
    Rannard, A
    Buck, D
    Bhala, N
    Newton, JL
    James, OFW
    Jones, DEJ
    [J]. GUT, 2005, 54 (11) : 1622 - 1629
  • [7] The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: Results of a 9 year follow-up
    Jones, David E.
    Al-Rifai, Ahmad
    Frith, James
    Patanwala, Imran
    Newton, Julia L.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 53 (05) : 911 - 917
  • [8] Fatigue in Primary Biliary Cirrhosis: Prevalence, Pathogenesis and Management
    Jopson, Laura
    Jones, David E. J.
    [J]. DIGESTIVE DISEASES, 2015, 33 : 109 - 114
  • [9] Medical progress: Primary biliary cirrhosis
    Kaplan, MM
    Gershwin, ME
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) : 1261 - 1273
  • [10] Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC)
    Kaps, Leonard
    Grambihler, Annette
    Yemane, Bethlehem
    Nagel, Michael
    Labenz, Christian
    Ploch, Pascal
    Michel, Maurice
    Galle, Peter R.
    Woerns, Marcus-Alexander
    Schattenberg, Joern M.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (10) : 3006 - 3013